Equities research analysts forecast that Merus N.V. (NASDAQ:MRUS) will report earnings per share (EPS) of ($0.69) for the current quarter, according to Zacks. Two analysts have provided estimates for Merus N.V.’s earnings. The lowest EPS estimate is ($0.77) and the highest is ($0.60). Merus N.V. posted earnings of ($0.35) per share during the same quarter last year, which would indicate a negative year-over-year growth rate of 97.1%. The business is scheduled to announce its next quarterly earnings results on Monday, November 6th.

On average, analysts expect that Merus N.V. will report full year earnings of ($3.84) per share for the current year, with EPS estimates ranging from ($4.05) to ($3.62). For the next year, analysts expect that the business will report earnings of ($4.01) per share, with EPS estimates ranging from ($4.85) to ($3.17). Zacks’ earnings per share averages are an average based on a survey of sell-side research analysts that cover Merus N.V..

A number of research analysts recently commented on MRUS shares. Zacks Investment Research cut Merus N.V. from a “hold” rating to a “sell” rating in a report on Saturday, July 15th. ValuEngine cut Merus N.V. from a “hold” rating to a “sell” rating in a report on Monday, October 2nd. Jefferies Group LLC reissued a “buy” rating and issued a $31.00 price target on shares of Merus N.V. in a report on Friday, July 14th. Finally, Royal Bank Of Canada started coverage on Merus N.V. in a report on Thursday, September 14th. They issued an “outperform” rating and a $28.00 price target on the stock. Two analysts have rated the stock with a sell rating, one has issued a hold rating and three have assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus price target of $30.50.

ILLEGAL ACTIVITY NOTICE: This article was originally posted by American Banking News and is owned by of American Banking News. If you are viewing this article on another site, it was illegally copied and republished in violation of U.S. & international copyright and trademark legislation. The correct version of this article can be viewed at https://www.americanbankingnews.com/2017/10/12/merus-n-v-mrus-expected-to-post-earnings-of-0-69-per-share.html.

Merus N.V. (MRUS) traded down 0.52% on Thursday, hitting $21.00. 13,836 shares of the company traded hands. The firm’s market capitalization is $407.32 million. Merus N.V. has a 1-year low of $13.13 and a 1-year high of $33.63. The firm’s 50 day moving average price is $18.38 and its 200 day moving average price is $18.38.

Institutional investors and hedge funds have recently modified their holdings of the company. Spark Investment Management LLC purchased a new stake in shares of Merus N.V. during the 1st quarter worth approximately $458,000. Renaissance Technologies LLC purchased a new stake in shares of Merus N.V. during the 1st quarter worth approximately $549,000. Victory Capital Management Inc. purchased a new stake in shares of Merus N.V. during the 1st quarter worth approximately $976,000. Iguana Healthcare Management LLC raised its holdings in shares of Merus N.V. by 16.7% during the 1st quarter. Iguana Healthcare Management LLC now owns 175,000 shares of the biotechnology company’s stock worth $4,268,000 after acquiring an additional 25,000 shares in the last quarter. Finally, Wellington Management Group LLP purchased a new stake in shares of Merus N.V. during the 1st quarter worth approximately $29,841,000. 32.16% of the stock is currently owned by institutional investors and hedge funds.

Merus N.V. Company Profile

Get a free copy of the Zacks research report on Merus N.V. (MRUS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Merus N.V. (NASDAQ:MRUS)

Receive News & Ratings for Merus N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merus N.V. and related companies with MarketBeat.com's FREE daily email newsletter.